Brexit Round Up Pharma (25th Nov. 2016)
Dods' Brexit Round Up is a unique sector-specific review of all recent developments that affect your area of interest. It will be produced weekly for a minimum of two years.
A one year subscription – amounting to 50 issues – can be yours for as little as £3,000.00 (excl. VAT), with a 33% discount available for purchases covering two or more sector reports.
Download a free sample to see how the Round Ups can help you stay up to date with breaking Brexit policy news.
This report will collate all key activity from the last week in Westminster, Whitehall, the European Commission, European Parliament and leading stakeholders as it related to the pharmaceutical and life sciences industry
In the UK this week the Prime Minister announced £2bn investment into research and development, which was further reiterated in the Chancellor’s Autumn Statement. The OBR, meanwhile, estimated that the referendum vote would add £58.7bn in additional borrowing over the next five years.